Cargando…
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
It is believed that genetic factors, immune system dysfunction, chronic inflammation, and intestinal microbiota (IM) dysbiosis contribute to the pathogenesis of colorectal cancer (CRC). The beneficial role played by the direct regulation of IM in inflammatory bowel disease treatment is identified by...
Autores principales: | Ding, Chenbo, Tang, Wendong, Fan, Xiaobo, Wu, Guoqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097518/ https://www.ncbi.nlm.nih.gov/pubmed/30147331 http://dx.doi.org/10.2147/OTT.S170626 |
Ejemplares similares
-
Peroxiredoxin 1 – an antioxidant enzyme in cancer
por: Ding, Chenbo, et al.
Publicado: (2016) -
Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model
por: Ding, Chenbo, et al.
Publicado: (2016) -
Overexpression of PEAK1 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling
por: Ding, Chenbo, et al.
Publicado: (2018) -
Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels
por: Ding, Chenbo, et al.
Publicado: (2017) -
Microbiota-directed biotherapeutics: considerations for quality and functional assessment
por: Fekete, Emily Ef, et al.
Publicado: (2023)